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Heat shock protein 70 (Hsp70) is an evolutionarily highly conserved molecular chaperone that promotes the survival of stressed cells by inhibiting lysosomal membrane permeabilization [1] [2] [3] [4] [5] , a hallmark of stress-induced cell death [6] [7] [8] [9] [10] . Clues to its molecular mechanism of action may lay in the recently reported stress-and cancer-associated translocation of a small portion of Hsp70 to the lysosomal compartment 1, 11 . Here we show that Hsp70 stabilizes lysosomes by binding to an endolysosomal anionic phospholipid bis(monoacylglycero)phosphate (BMP), an essential co-factor for lysosomal sphingomyelin metabolism [12] [13] [14] . In acidic environments Hsp70 binds with high affinity and specificity to BMP, thereby facilitating the BMP binding and activity of acid sphingomyelinase (ASM). The inhibition of the Hsp70-BMP interaction by BMP antibodies or a point mutation in Hsp70 (Trp90Phe), as well as the pharmacological and genetic inhibition of ASM, effectively revert the Hsp70-mediated stabilization of lysosomes. Notably, the reduced ASM activity in cells from patients with NiemannPick disease (NPD) A and B-severe lysosomal storage disorders caused by mutations in the sphingomyelin phosphodiesterase 1 gene (SMPD1) encoding for ASM 15 -is also associated with a marked decrease in lysosomal stability, and this phenotype can be effectively corrected by treatment with recombinant Hsp70. Taken together, these data open exciting possibilities for the development of new treatments for lysosomal storage disorders and cancer with compounds that enter the lysosomal lumen by the endocytic delivery pathway.
To test whether the lysosomal localization is crucial for the reported ability of Hsp70 to stabilize lysosomal membranes 1 , we took advantage of the endocytic machinery of cells to target recombinant Hsp70 (rHsp70) into the lysosomes. Immunocytochemical and biochemical analysis of U-2-OS osteosarcoma cells incubated with fluorochromelabelled rHsp70 (rHsp70-AF488) showed effective uptake of rHsp70, its specific co-localization with late endosomal and lysosomal markers, and binding to lysosomal membranes (Fig. 1a, b and Supplementary  Fig. 1 ). Using real-time imaging to monitor lysosomal membrane integrity ( Fig. 1c and Supplementary Movie 1), we showed that the endocytosed rHsp70 protected lysosomes against photo-oxidation (Fig. 1d) . Furthermore, short interfering RNA (siRNA)-mediated depletion of Hsp70 sensitized the lysosomes to photo-oxidation, and this effect was fully reverted by endocytosed rHsp70, aptly demonstrating that the protective effect of endogenous Hsp70 is mediated by the small fraction of the protein in the lysosomal lumen (Fig. 1e) . In spite of similar uptake (data not shown), no lysosomal stabilization was observed with recombinant Hsc70 and Hsp70-2, which share 86% and 84% amino acid sequence homology with Hsp70 (ref. 16 ), respectively (Fig. 1d) .
The presence of Hsp70 in the lysosomal membranes and its ability to survive the hydrolytic lysosomal environment suggest that it binds to the lysosomal membrane lipids. Thus, we investigated the interaction of Hsp70 with palmitoyl-oleoyl-phosphatidylcholine (POPC) large unilamellar vesicles (LUVs) containing various anionic lipids, that is, palmitoyl-oleoyl-phosphatidylserine (POPS; primarily in plasma membrane), cardiolipin (primarily mitochondrial) and BMP (primarily in late endosomes/lysosomes). Taking into account the increasingly acidic milieu of the endolysosomal compartment after maturation to lysosomes, we compared the protein-lipid interactions in neutral (pH 7.4) and acidic (pH 4.5) conditions (Fig. 2a) . At pH 7.4, rHsp70 caused a small relative change in the 90u light scattering in the tested liposomes, indicating weak binding. Notably, lowering the pH to 4.5 greatly enhanced the binding to all negatively charged lipids, and especially to BMP, whereas the binding to POPC was not significantly increased after acidification (Fig. 2a) . The high affinity binding of Hsp70 to BMP in acidic pH was confirmed in an independent set of BIAcore experiments (Fig. 2d) . Notably, BMP antibodies delivered to the endolysosomal compartment by endocytosis 17 effectively inhibited the ability of rHsp70 to stabilize the lysosomes in living cells, suggesting that Hsp70-BMP binding is essential for the pro-survival function of Hsp70 (Fig. 2b) .
To investigate which part of the Hsp70 protein is responsible for the BMP binding, we measured the fluorescence shift of tryptophan residues after the docking of rHsp70 and its mutants into BMPcontaining liposomes. The loss of signal in relative peak fluorescence intensity for the Hsp70 mutant lacking amino acids 119-426 in the amino-terminal ATPase domain (rHsp70-DATP), but not for that lacking amino acids 437-617 in the carboxy-terminal peptidebinding domain (rHsp70-DPBD), indicated that the ATPase domain was required for the high-affinity binding of Hsp70 to BMP (Fig. 2c) . Next, we substituted the two tryptophan residues in Hsp70 with phenylalanine (Trp90Phe and Trp580Phe) and studied which tryptophan is responsible for the fluorescence shift induced by lipid binding. The reduction of the signal with rHsp70(Trp90Phe) only indicated that the N terminus of the protein docked into the lipid layer (Fig. 2c) . A more quantitative BIAcore analysis of the BMPrHsp70 interaction confirmed that Hsp70 interacted with BMP mainly through its ATPase domain (Fig. 2d) . Surprisingly, the Trp90Phe mutation specifically abolished the interaction between rHsp70 and BMP while retaining the structural (folding as analysed by far-and near-ultraviolet circular dichroism) and functional (luciferase folding and ATP hydrolysis) aspects of the Hsp70 chaperone ( Fig. 2d and data not shown) . Thus, the rHsp70(Trp90Phe) mutant provided us with an invaluable tool to test further whether the direct interaction between Hsp70 and BMP endows Hsp70 with its lysosome protective attributes. Indeed, the rHsp70(Trp90Phe) mutant had completely lost its ability to protect the lysosomal membranes against photo-oxidation-induced destabilization, whereas the rHsp70(Trp580Phe) mutant showed the same protective effect as the wild-type protein (Fig. 2e) . Notably, mutant Hsp70 proteins were endocytosed essentially as effectively as the wild-type Hsp70 (data not shown). Thus, we conclude that the binding of Hsp70 to BMP is essential for the lysosome-stabilizing effect of Hsp70.
Because the BMP concentration increases in endocytic vesicles as the endosomes mature to lysosomes 14 , pH-regulation might be the way by which Hsp70 is targeted to lysosomes. The theoretical isoelectric point (pI) of the ATPase domain of Hsp70 is 1.72 units higher than the peptide-binding domain (6.62 versus 4.9; as calculated using PROTPARAM, EXPaSy proteomics server, Swiss Institute of Bioinformatics). This characteristic suggests that at acidic pH, the ATPase domain is preferentially positively charged, which could facilitate its interaction with anionic lipids. Our data demonstrating the dependence of Hsp70-BMP interaction on acidic pH and the ATPase domain support this theory. Furthermore, molecular modelling of the electrostatic surface of the ATPase domain of Hsp70 showed that it forms an almost wedge-like structure with a predominantly positive charge at the bottom of the wedge containing Trp 90, possibly explaining the profound effect of the Trp90Phe mutation on the ability of Hsp70 to interact with BMP and stabilize lysosomes (Fig. 2f) .
Prompted by the fact that BMP binds ASM with high affinity and stimulates its ability to hydrolyse sphingomyelin 13, 14 , we next asked whether Hsp70 could modulate ASM activity. The BIAcore analysis showed that pre-treatment of the BMP-containing LUVs with rHsp70 at sub-equimolar concentrations significantly facilitated the subsequent binding of recombinant ASM (rASM), whereas excess rHsp70 had an inhibitory effect (Fig. 3a) . Remarkably, Hsp70 transgenic murine embryonic fibroblasts (Hsp70-MEFs), which are protected against stress-induced lysosomal damage 1 , showed significantly higher ASM activity than wild-type MEFs, as evidenced by an in vitro enzyme activity assay and quantitative analysis of total cellular ceramides (Fig. 3b, c and Supplementary Fig. 2 ). Furthermore, the treatment of wild-type MEFs with rHsp70 at a lysosomestabilizing concentration (300 nM) significantly increased the ASM activity to a comparable level to that in Hsp70-MEFs (Fig. 3b) . To test whether the Hsp70-associated activation of ASM could be responsible for the lysosome-stabilizing effect of Hsp70, we treated the cells with desipramine, a pharmacological ASM inhibitor 18 . Notably, desipramine reverted the lysosomal stress resistance of Hsp70-MEFs to the level of wild-type MEFs, as evidenced by accelerated loss of lysosomal membrane integrity after photo-oxidation (Fig. 3d) . The lysosome-protective role of ASM was confirmed by the finding that lysosomes in U-2-OS cells depleted for ASM by three non-overlapping siRNAs, as well as in fibroblasts from a patient with NPD A (83/24), showed extreme sensitivity to photo-oxidation-induced damage (Fig. 3e, f, Supplementary Fig. 3 and Supplementary Movie 2). Notably, rHsp70 was also capable of enhancing the enzymatic activity of the endogenous mutated ASM as well as rASM delivered to the lysosomes by the endocytic pathway in NPD patient cells (Fig. 4a) . It should be noted that akin to rHsp70, rASM also co-localized with the lysosomes (Supplementary Fig. 4 ). The increased ASM activity obtained by loading the lysosomes with rHsp70, rASM or the combination of the two proteins correlated with their ability to stabilize the lysosomes and to normalize the volume of the markedly enlarged lysosomal compartment in patient fibroblasts (Fig. 4a-c) . Notably, the rHsp70(Trp90Phe) mutant that was unable to bind to BMP in vitro (Fig. 2d ) also failed to normalize the lysosomes in NPD A cells (Fig. 4c) . The ability of rHsp70 to revert the lysosomal pathology was not limited to a single ASM mutation, but it significantly decreased the volume of the lysosomal compartment and the sphingomyelin levels also in NPD A cells from another patient (no. 2), as well as in NPD B fibroblast lines carrying different mutations (Fig. 4c, d and Supplementary Fig. 5 ). Taken together, our data indicate that the Hsp70-BMP interaction stabilizes lysosomes by a mechanism involving the regulation of sphingomyelin metabolism rather than direct physical stabilization of the membrane. Such an indirect effect is supported by the facts that a large part of the endolysosomal Hsp70 resides on the inner membranes 1 , and that BMP is exclusively localized to these membranes, where its major function is to support the disintegration and lipid extraction from lipid vesicles by ASM and sphingolipid activator proteins 14 . Interestingly, the ASM-mediated conversion of sphingomyelin to ceramide enhances membrane acyl chain order and increases lateral packing of lipids in vitro 19 . Furthermore, ASM-mediated increase in lysosomal ceramide concentration modifies the steric conformation of lysosomal membranes in living cells and thereby facilitates their fusion with other intracellular vesicles and plasma membrane 20, 21 . Thus, the changes in the lysosomal membrane composition and volume as a result of the ceramide-induced enhanced fusion capacity may contribute to the Hsp70-mediated increase in lysosomal stability. Conversely, various apoptotic stimuli induce the translocation of ASM to the outer leaflet of the plasma membrane, where ceramide can form lipid microdomains that function as sites for activation of membrane-associated signalling molecules involved in apoptotic signalling 22 . Thus, ceramide may have opposing effects on cell survival depending on whether it is produced inside the lysosome or in the plasma membrane.
The described molecular mechanism underlying the lysosomestabilizing effect of Hsp70 may explain the recently reported surprising neuroprotective and behavioural effects of extracellular Hsp70 administered either to the sites of injury or intranasally [23] [24] [25] . Taken together with the reported neuronal effects of exogenous Hsp70 in vivo, our data greatly encourage the pre-clinical testing of the efficacy of exogenously administered rHsp70 alone or in combination with rASM in animal models of NPD. Liposomes were injected until equilibrium (100 s), and 150, 300 or 750 nM recombinant proteins in sodium acetate buffer (50 mM, pH 4.5) were injected for 200 s at a flow rate of 20 ml min 21 followed by a dissociation phase for 10 min. DRU is the difference between the response signal measured after liposome equilibrium and protein-liposome equilibrium. e, U-2-OS cells were left untreated (control) or incubated with indicated recombinant Hsp70 proteins (300 nM) for 24 h, and analysed for lysosomal integrity after photo-oxidation. 
METHODS SUMMARY
NPD A fibroblasts originate from a 5-month-old patient with hepatosplenomegaly (83/24) and an unknown source (no. 2). NPD B fibroblasts with homoallelic His412Tyr and Arg289His mutations are of Arabic and unknown parentages, respectively. The residual ASM activities in NPD fibroblasts are presented in Supplementary Fig. 6 . Hsp70 transgenic and appropriate control MEFs were generated as described previously 1 . Recombinant proteins were generated using the pET-16b vector system and Ni
21
-affinity-purification (Novagen), and labelled with Alexa Fluor 488 according to manufacturers protocol (Molecular Probes). To analyse the lysosomal integrity, we developed a real time imaging method of cells stained with acridine orange, a metachromatic weak base that accumulates in the acidic compartment of the cells staining them red and sensitizing them to photooxidation 1, 26 . The photo-oxidation-induced loss of the lysosomal pH-gradient and leakage of acridine orange to the cytosol from individual lysosomes was quantified visually as a 'loss of red dots' or as a decrease in red and increase in green fluorescence by Zeiss LSM DUO Software in fibroblasts (see Supplementary Movies 1  and 2 ). The tryptophan fluorescence spectra and liposome 90u light scattering were measured in 20 mM HEPES or MES, 0.1 mM EDTA, pH 7.4 or 4.5, essentially as described previously 27, 28 . Surface plasmon resonance measurements were performed with immobilized LUVs using a BIAcore 2000 system as described 18 . siRNAs were transfected with Oligofectamine (Invitrogen). Immunodetection was performed with standard protocols. ASM activity was analysed using an Amplex Red Sphingomyelinase Assay Kit from Molecular Probes, with modifications described previously 20 . Lipid analysis was performed using an Esquire iontrap electrospray mass spectrometer from Bruker/Hewlett-Packard, and the data were analysed using Bruker DataAnalysis for LC/MSD Trap version 5.2. Statistical analysis was performed using a two-tailed, paired Student's t-test, and all groups of data were tested for the comparability of their variances using an F-test.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
